Safety First: Perspective on Patient-Centered Development of AAV Gene Therapy Products.

ABSTRACT:

SUBMITTER: Byrne BJ 

PROVIDER: S-EPMC5911637 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature